Drugs / denovoSkin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02145130 | May 2014 → Mar 2021 | large congenital melanocytic nevus | University of Zurich | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | denovoSkin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02145130 ↗ |
| Modality | Other / unclassified | “Autologous tissue-engineered dermo-epidermal skin substitute” NCT02145130 ↗ |
| Route | Other | “transplanted onto the wound bed” NCT02145130 ↗ |